One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat

ACS Chemical Neuroscience

Volumn 4, Issue 1, 2013, Pages 141-148

  Davis, Robert Patrick ^a   Szasz, Theodora ^a   Garver, Hannah ^a   Burnett, Robert ^a   Tykocki, Nathan R ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

5 HT; blood pressure; hypertension; vascular reactivity

Indexed keywords

ACETYLCHOLINE; DEOXYCORTICOSTERONE ACETATE; PHENYLEPHRINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STRIP; ARTICLE; BLOOD PRESSURE MEASUREMENT; DRUG BLOOD LEVEL; DRUG MECHANISM; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; TELEMETRY; TREATMENT DURATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; DESOXYCORTICOSTERONE; HYPERTENSION; INFUSIONS, INTRAVENOUS; ISOMETRIC CONTRACTION; MALE; MINERALOCORTICOIDS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

RATTUS;

EID: 84872565579     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300114a     Document Type: Article

References (38)

1. Campese, V. M., Ku, E., and Park, J. (2011) Sympathetic renal innervation and resistant hypertension Int. J. Hypertens. 2011, 814354
2. Erspamer, V. and Asero, B. (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine Nature 169, 800-801
3. Rapport, M. M., Green, A. A., and Page, I. H. (1948) Serum vasoconstrictor (serotonin): IV Isolation and characterization J. Biol. Chem. 176, 1243-1251
4. Dahlstroem, A. and Fuxe, K. (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. 1. Demonstration of monoamines in the cell bodies of brain stem neurons Acta Physiol. Scand. 232 (Suppl) 1-55
5. Brenner, B., Harney, J. T., Ahmed, B. A., Jeffus, B. C., Unal, R., Mehta, J. L., and Kilic, F. (2007) Plasma serotonin levels and the platelet serotonin transporter J. Neurochem. 102, 206-215 (Pubitemid 46906271)
6. Fetkovska, N., Pletscher, A., Ferracin, F., Amstein, R., and Buhler, F. R. (1990) Impaired uptake of 5-hydroxytryptamine in platelet in essential hypertension: clinical relevance Cardiovasc. Drugs Ther. 4, 105-109 (Pubitemid 20106962)
7. 2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats Am. J. Physiol.: Heart Circ. Physiol. 276, 944-952
8. Watts, S. W. (2005) 5-HT in systemic hypertension: foe, friend or fantasy Clin. Sci. 08, 399-412 (Pubitemid 40685670)
9. Vanhoutte, P., Amery, A., Birkenhager, W., Breckenridge, A., Buhler, F., Distler, A., Dormandy, J., Doyle, A., Frohlich, E., Hansson, L., Hedner, T., Hollenberg, N., Jensen, H.-E., Lund-Johansen, P, Meyer, P., Opie, L., Robertson, I., Safar, M., Schalekamp, M., Symoens, J., Trap-Jensen, J., and Zanchetti, A. (1988) Serotonergic mechanisms in hypertension: focus on the effects of ketanserin Hypertension 11, 111-133 (Pubitemid 18086318)
10. Thompson, L. P. and Webb, R. C. (1987) Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension Hypertension. 9, 277-281 (Pubitemid 17035231)
11. Diaz, J., Ni, W., Thompson, J., King, A., Fink, G. D., and Watts, S. W. (2008) 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats J. Pharmacol. Exp. Ther. 325, 1031-1038 (Pubitemid 351724318)
12. Watts, S. W., Morrison, S. F., Davis, R. P., and Barman, S. M. (2012) Serotonin and blood pressure regulation Pharmacol. Rev. 64 (2) 359-388 (also ref 28)
13. Davis, R. P., Pattison, J., Thompson, J. M., Tiniakov, R., Scrogin, K., and Watts, S. W. (2012) 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved BMC Pharmacol. 12, 4
14. Davis, R. P., Linder, A. E., and Watts, S. W. (2011) Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytrytamine to lower blood pressure Naunyn Schmuedebergs Arch. Pharmacol. 388 (5) 543-546
15. Tan, T., Watts, S. W., and Davis, R. P. (2011) Drug delivery: enabling technology for drug discovery and development. iPRECIO microinfusion pump: programmable, refillable and implantable Front Pharmacol. 2, 44
16. Fregly, M. J., Lockley, O. E., and Summers, C. (1987) Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats J. Hypertens. 5 (5) 621-628
17. Clark, D., Ahmed, M. I, and Calhoun, D. A. (2012) Resistant hypertension and aldosterone: an update Can. J. Cardiol. 28, 318-325
18. Acelaiado, M. C., Pison, R., Dudenbostel, T., Dell'Italia, L. J., Cartmill, F., Zhang, B., Cofield, S. S., Oparil, S., and Calhoun, D. A. (2012) Refractory hypertension: definition, prevalence, and patient characteristics J. Clin. Hypertens. 14, 7-12
19. Schenk, J. and McNeill, J. H. (1992) The Pathogenesis of DOCA-Salt Hypertension J. Pharmacol. Toxicol. Methods 3, 161-170
20. Crofton, J. T., Share, L., Shade, R. E., Lee-Kwon, W. J., Manning, M., and Sawyer, W. H. (1979) The importance of vasopressin in the development and maintenance of DOCA-salt hypertension in the rat Hypertension 1, 31-38
21. Yemane, H., Busauskas, M., Burris, S. K., and Knuepfer, M. M. (2009) Neurohumoral mechanisms in deoxycortictosterone acetate (DOCA)-salt hypertension in rats Exp. Physiol. 95.1, 51-55
22. Van de Voorde, J. and Leusen, I. (1986) Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats Am. J. Physiol. 250, H711-H717
23. Cohen, R. A., Shepherd, J. T., and Vanhoutte, P. M. (1983) 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries Am. J. Physiol. 245, H1077-H1080
24. Watts, S. W., Schenck, K. W., and Cohen, M. L. (1994) Selective desensitization of 5-hydroxytryptamine 2A receptor mediated contraction in guinea pig trachea Can. J. Physiol. Pharmacol. 72 (5) 463-470 (Pubitemid 24246357)
25. Munoz-Castaneda, J. R., Montilla, P., Padillo, F. J., Bujalance, I., Munoz, M. C., Muntane, J., and Tunez, I. (2006) Role of serotonin in cerebral oxidative stress in rats Acta Neurobiol. Exp. 66, 1-6
26. Iyer, A., Chan, V., and Brown, L. (2010) The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress Curr. Cardiol. Rev. 6 (4) 291-297
27. Cordellini, S., Nigro, D., Carvalho, M. H., Fortes, Z. B., and Scivoletto, R. (1988) Reactivity of macro- and microvessels of DOCA-salt hypertensive rats: role of the endothelial cell Braz. J. Med. Biol. Res. 21 (4) 845-9
28. Lariviere, R., Day, R., and Schriffrin, E. L. (1993) Increased expression of endothelin-1 gene in blood vessel of deoxycorticosterone acetate-salt hypertensive rats Hypertension 21, 916-920 (Pubitemid 23166939)
29. Linder, A. E., Beggs, K. M., Burnett, R. J., and Watts, S. W. (2009) Body distribution of infused serotonin in rats Clin. Exp. Pharmacol. Physiol. 36, 599-601
30. Borgdoff, P., Fekkes, D., and Tangelder, G. J. (2002) Hypotension caused by extracorporal circulation Circulation 106, 2588-2593
31. Meuer, S., Ecker, U., Hadding, U., and Bitter-Suermann, D. (1981) Platelet serotonin release by C3a and C5a: two independent pathways of activation J. Immunol. 126, 1506-1509 (Pubitemid 11149254)
32. Rodriguez de la Torre, B., Dreher, J., Malevany, I., Bagli, M., Kolbinger, M., Omran, H., Lüderitz, B., and Rao, M. L. (2001) Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients Ther. Drug Monit. 4, 435-440 (Pubitemid 32708931)
33. Das, Y. T., Bagchi, M., Bagchi, D., and Preuss, H,G. (2004) Safety of 5-hydroxy- l -tryptophan Toxicol. Lett. 150, 111-122
34. Abe, C., Tashiro, T., Tanaka, K., Ogihara, R., and Morita, H. (2009) A novel type of implantable and programmable infusion pump for small laboratory animals J. Pharmacol. Toxicol. Methods 59 (1) 7-12
35. Umegaki, K., Nakamura, K., Ikeda, M., Inoue, Y., and Tomita, T. (1989) Changes in platelet function due to hypertension: comparison of experimental hypertension with spontaneous hypertension in rats J. Hypertens. 7, 13-19 (Pubitemid 19059099)
36. Bulat, M. and Supek, K. (1968) Passage of 5-hydroxytryptamine through the blood brain barrier, its metabolism in the brain and elimination of 5-hydroxytryptamine from brain tissue J. Neurochem. 15, 383-389
37. Westergaard, W. (1975) The effect of serotonin on the blood brain barrier to proteins Acta Neuropathol. 32, 27-42
38. Westergaard, E. (1978) The effect of serotonin on the blood brain barrier to proteins J. Neural Transm., Suppl. 14, 9-15